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http://dx.doi.org/10.1016/j.gmbhs.2Abstract The antidiabetic therapeutic approach is to reduce gastrointestinal glucose produc-
tion and absorption through the inhibition in carbohydrate-digesting enzymes such as a-amylase
and a-glucosidase. The present study was designed to investigate the a-amylase and a-glucosi-
dase inhibition in the n-hexane fraction of sepal of Salmalia malabarica. The fraction showed
concentration-dependent a-amylase (IC50Z 50.17 mg/L) and a-glucosidase (IC50Z 61.04 mg/L)
inhibitory activity. The positive in vitro enzyme inhibition tests results were confirmed with
an oral starch tolerance test with 18 hour fasted normoglycemic rats. Phytochemical study of
the said plant part fraction revealed that is rich in total phenolic contents, flavonoids, and
flavonol, which may be responsible for its pharmacological activity. In an acute toxicity study,
the n-hexane fraction up to the dose level of 3000 mg/kg body weight did not exhibit any
lethality or toxic symptoms. From these results, it may be concluded that the n-hexane fraction
may have an inhibitory effect on intestinal a-amylase and a-glucosidase activity, and can be
used effectively as a safer alternative therapy to control postprandial hyperglycemia.
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In vitro antidiabetic activities of S. malabarica 49Introduction
Diabetes mellitus is a chronic disease characterized by
elevated blood glucose levels, and disturbances in carbo-
hydrate, protein, and fat metabolism.1 In recent years
diabetes mellitus has become a major health problem
worldwide, reaching epidemic proportions.2 Epidemiolog-
ical studies and clinical trials strongly support the notion
that hyperglycemia is the main cause of complications
related to coronary artery disease, cardiovascular disease,
renal failure, blindness, limb amputation, neurological
complications, and premature death.3 Alpha-glucosidase
cleaves glycosidic bonds in complex carbohydrates to
release absorbable monosaccharides. Recent studies sug-
gest that postprandial hyperglycemia could induce the
nonenzymatic glycosylation of various proteins, resulting in
the development of chronic complications. Therefore,
control of postprandial plasma glucose levels is critical in
the early treatment of diabetes mellitus and in reducing
chronic vascular complications.4 Inhibitors of a-glucosidase
display useful antihyperglycemic effects.5 Synthetic hypo-
glycemic agents produce serious side effects, whereas
drugs derived from medicinal plants are frequently
considered safe and cost effective.6 The search for new
pharmacologically active agents obtained by screening
natural sources such as medicinal plants or their fraction
can lead to potent and specific inhibitors for a-amylase.7
Complex polysaccharides must be digested by enteric
digestive enzymes including a-glucosidase because only
monosaccharides can be absorbed from the intestinal
lumen and transported into blood circulation. Therefore, a-
glucosidase inhibitors such as acarbose, miglitol, and
voglibose are widely used, either alone or in combination,
with insulin secretagogues in patients with type 2 dia-
betes.8,9 Long-term day-to-day management of diabetes,
with acarbose is well tolerated and can improve glycemic
control as a monotherapy, as well as in combination
therapy.10
Salmalia malabarica is a large and tall deciduous tree of
the family of Malvaceae. It is beneficial in acne and skin
eruptions.11 S. malabarica also possesses antibacterial and
antifungal properties.12 Our previous studies have reported
the antidiabetic activity of the sepal of S. malabarica13,14
and thus the present study examined the inhibitory effect
from the sepal of S. malabarica on a-amylase and a-
glucosidase activities.Materials and methods
Materials
2-Chloro-4-nitrophenol a-D-maltotrioside and p-nitro-
phenyl-a-D glucopyranoside were purchased from Sigma-
Aldrich Chemical Co, St Louis, MO, USA. Other chemicals,
such as FolineCiocalteureagent, aluminum trichloride
(AlCl3), gallic acid, and quercetin were purchased from
Sisco Research Laboratory, Mumbai, India. Sepals of S.
malabarica were collected from Midnapore, West Bengal,
India. A voucher specimen of the plant (No. VU/BMLSM/SM-
01) was deposited in the herbarium center of the Botanyand Forestry Department, Vidyasagar University, Mid-
napore. The sepals were dried in an incubator at 37C.
Preparation of hydro-methanolic (2:3) extract
Pulverized sepals (1000 g) of S. malabarica were placed in a
20 L percolator and macerated with 10 L hydro-methanolic
solution (H2O:MeOH Z 40:60) at 25C to avoid any degra-
dation or deactivation of the active compounds. The slurry
was stirred intermittently for 1 hour and left overnight. The
extract was collected on the second day after 24 hours
of extraction process and freshly prepared 5 L hydro-
methanolic solution was added to the extraction chamber
and the slurry was stirred again with a glass rod. The same
procedure was repeated again on the third day with another
5 L solvent mixture and the last extract was collected on the
fourth day. The extract was filtered first by cotton filter and
then by Whatman No.1 filter paper. The filtrate was evap-
orated under reduced pressure by Rotavapour (R124; BUCHI
Labortechnik AG, Flawil, Switzerland) at 40C for complete
removal of methanol. Finally plain aqueous filtrate (9.5 L
free from methanol) was lyophilized with a VirTis bench top
K lyophilizer (Atico Medical Pvt. Ltd., Haryana - 133 001,
India). The lyophilized extract (260 g) was collected and put
into the amber colored glass containers which were finally
stored at 4C under vacuum for subsequent fractionation
and experimental studies. The lyophilized extract was a
mixture of dark brownish sticky layer and light brownish
solid powder, slightly hygroscopic in nature.
Preparation of n-hexane fraction
In a 5 L separating flask, 260 g of lyophilized extract of S.
malabarica were dissolved with 2 L of hydro-methanolic
(H2O:MeOH Z 40:60) solution and solvent fractionation
was carried out using solvents with increasing polarity (n-
hexane, chloroform, ethyl acetate, and n-butanol). Thin
layer chromatography was carried out to monitor the
progress in fractionation. All fractionates were collected
separately and dried under reduced pressure
(20e200 mbar) using the Rotavapourat at 40C. Finally from
260 g lyophilized extract of S. malabarica 3.7 g n-hexane
fraction, 15.4 g chloroform fraction, 56.8 g ethyl acetate
fraction, and 87.5 g n-butanol fractions were obtained.
Biochemical assay of a-amylase inhibitory activity
The a-amylase inhibition assay was performed according to
standard methods.15 Briefly, the total assay mixture con-
taining 200 mL of 0.02 M sodium phosphate buffer, 20 mL of
enzyme, and the plant fraction in the concentration range
20e100 mg/L were incubated for 10 minutes at room tem-
perature followed by addition of 200 mL of 1% starch in all the
test tubes. The reaction was terminated with addition of
400 mL of 3,5-dinitrosalycylic acid color reagent, placed in a
boiling water bath for 5 minutes, colored at room tempera-
ture, and diluted with 15 mL of distilled water and the
absorbance measured at 540 nm. The control samples were
also prepared accordingly without any plant fraction and
were compared with the test samples containing various
concentrations of plant fraction prepared with a different
Figure 1 Inhibitory effect of n-hexane fraction of sepal of
Salmalia malabarica on a-amylase activity. Each plot repre-
sents the mean  standard error of mean from six
observations.
50 D. De et al.solvent preparedwithdimethyl sulfoxide (DMSO). The results
were expressed as % inhibition calculated using the formula:
%InhibitionZ
Abs Control  Abs Sample
Abs Control
 100
Where Abs Control is the absorbance without sample and
Abs Samples is the absorbance of sample fraction.
The IC50 values (inhibitor concentration at which 50%
inhibition of the enzyme activity occurs) of the plant
fraction were determined by performing the assay as above
with concentrations of the plant fraction ranging from 20 mg
to 100 mg.
Biochemical assay of a-glucosidase inhibition assay
The assessment of intestinala-glucosidase inhibitory activity
was based on the modified method previously described.16
Briefly, 100 mg of rat intestinal acetone powder was ho-
mogenized in 3 mL of 0.9% NaCl solution. The solution was
centrifuged at 12,000 g for 30minutes and then assayed. The
crude enzyme solution (as maltase assay, 10 mL; as sucrase
assay, 30 L) was incubated with 30 mL maltose (86 mM) or
40 mL sucrose (400 mM), 10 ml of the fraction at various
concentrations, followed by the addition of 0.1 M phosphate
buffer, pH 6.9 to give a final volume of 100 mL. The reaction
was incubated at 37C for 30 minutes (maltase assay) or 60
minutes (sucrose assay). Thereafter, the mixtures were
suspended in boiling water for 10 minutes to stop the reac-
tion. The concentration of glucose released from the reac-
tion mixtures were determined by the glucose oxidase
method with absorbance at a wavelength of 450 nm. Intes-
tinal a-glucosidase inhibitory activity was expressed as per-
centage inhibition using the following formula.
%InhibitionZ
Abs Control  Abs Sample
Abs Control
 100
Oral starch tolerance test
The oral starch tolerance test (OSTT) was performed with
plant fraction at concentrations of 200 mg/kg, 400 mg/kg,
600 mg/kg, and 800 mg/kg body weight on Wister albinor-
ats. Blood glucose levels in rats treated with plant fraction
and drugs (acarbose) were measured at preloading and
different durations of postloading with starch.17
Determination of total phenolic contents, total
flavonoid compounds, and total flavonols
The total phenolic content (TPC) was estimated using
FolineCiocalteu reagent according to Atanassova et al and
expressed as mg/g gallic acid equivalent (GAE).18
Total flavonoid content was determined using the
method of Venugopal and Devarajan.19 A yellow color
indicating the presence of flavonoids and absorbance was
measured at 420 nm. Total flavonoid content was expressed
interms of mg quercetin equivalents/g of fraction.
The total flavonol content was determined using AlCl3
and sodium acetate anhydrous powder by the method of
Ashafa et al.20Acute toxicity studies
An acute toxicity study for the test fraction of the plant was
carried out using Organization for Economic Cooperation
and Development guideline 425 and following the published
method using different doses of the n-fraction.21 The rats
were pragmatic continuously for 2 hours for behavioral,
neurological, and autonomic profile and after periods of 24
hours and 72 hours for any lethality.
Statistical analysis
All the data were evaluated statistically using one-way
analysis of variance (ANOVA) followed by multiple com-
parison two tailed t test by using Statistica software
(version 6.0, Statistica Lab Corporation, New York, USA).
p value of <0.05 was considered to indicate statistical
significance. Data are presented as mean  standard error
of the mean.Results
In vitro a-amylase inhibition study
The n-hexane fraction of S. malabarica showed good
inhibitory activities for a-amylase with the IC50 value of
50.17 mg/L as compared to standard acarbose having
IC50value 47.19 mg/ml (Fig. 1).
In vitro a-glucosidase inhibition study
The in vitro a-glucosidase inhibitory studies demonstrate
that n-hexane fraction of S. malabarica has inhibitory ac-
tivity. The percentage inhibition at 100 mg/L, 80 mg/L,
60 mg/L, 40 mg/L, and 20 mg/L of plant fraction showed a
concentration-dependent reduction in percentage inhibi-
tion with IC50 value of 61.04 mg/L as compared to standard
acarbose (IC50 Z 54.64 mg/L; Fig. 2).
Figure 2 Inhibitory effect of n-hexane fraction of sepal of
Salmalia malabarica on a-glucosidase activity. Each plot rep-
resents the mean  standard error of mean from six
observations.
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compounds, and total flavonols contents
The TPC, total flavonoid compounds, and total flavonols of
n-hexane fraction were 86.72  0.42 mg GAE/g,
217.28  0.97 mg quercetin equivalents/g and
138.63  0.69 mg rutin/g, respectively (Table 1).Oral starch tolerance test (OSTT)
The blood glucose level was significantly lower in acarbose
or different doses of fraction treated groups with respect to
the control group (Table 2). Although there was no signifi-
cant variation in blood glucose level after treatment with
fraction at 200 mg/kg, 400 mg/kg, and 600 mg/kg body
weight when comparison was made with the acarbose
treatment group.Acute toxicity study
In the acute toxicity study, n-hexane fraction up to the dose
level of 3000 mg/kg body weight did not exhibit any
lethality or toxic symptoms. There was no mortality or
morbidity observed in animals in the 24-hour and 72-hour
periods following oral administration at all selected dose
levels of these n-hexane fraction. No tremors, salivation,
diarrhea, sleep, coma, death, or unusual behaviors such as
walking backward or reactivity to handling were observed.Table 1 Determination of phenolic contents, flavonoids, and to
Plant fraction Phenolic contents (mg GAE/g) Flav
n-Hexane fraction of
S. malabarica
86.72  0.42 217.
Data are expressed as means  standard error of the mean from thre
GAE Z gallic acid equivalent; QE Z quercetin equivalent.The lethal dose 50 value (LD 50) for oral administration of
this n-hexane fraction is>3000 mg/kg body weight(Table 3).
Discussion
Alpha-amylase and a-glucosidase play major roles in car-
bohydrate digestion and absorption. The enzymes degrade
polysaccharides and oligosaccharides to monosaccharides
before they can be absorbed. The inhibition of these en-
zymes would delay the degradation of the complex sugars
such as starch and prolong overall carbohydrate digestion
time which would in turn cause a reduction in the rate of
glucose absorption and consequently of the increase of
postprandial glucose concentration.22 A prominent pathway
for glucose production from food intake is the breakdown of
carbohydrates and/or sucrose by amylases or glycoside
hydrolyses in the intestine. Therefore, preventing an
excessive postprandial blood glucose rise or maintaining
blood glucose limit within the normal range by controlling
glucose production from food sources using an oral a-
amylase and a-glucosidase inhibitor would be an effective
management for noneinsulin-dependent diabetes mellitus
patients. Our in vitro studies demonstrate an appreciable
a-amylase and a-glucosidase inhibitory activity of n-hexane
fraction of S. malabarica with an IC50 values 50.17 g/L and
61.04 g/L respectively. The tendency of this n-hexane
fraction to delay the quick digestion of starch and lengthen
the duration of carbohydrate absorption over time, may
reduce the peak blood glucose.22
The study also revealed that the n-hexane fraction was
rich in phenolic, flavonoids, and flavonols. TPC of the n-
hexane fraction of S. malabarica was estimated by the
FolineCiocalteu method as 86.72 mg GAE/g of dry n-hex-
ane fraction. The total flavonoid content of the selected
plant fraction was estimated by using AlCl3 colorimetric
technique in terms of quercetin equivalents as 217.28 mg
of quercetin equivalent/g of fraction. The total flavonol of
n-hexane fraction S. malabarica was estimated by AlCl3
and sodium acetate anhydrous powder method as
138.63 mg rutin/g of fraction. It has been acknowledged
that phenolic content, flavonoids, and flavonols show sig-
nificant antioxidant action on human health. The flavonoids
act through scavenging or chelating process.23 Animals in
all groups did not exhibit any sign of adverse effect up to
the dose level of 3000 mg/kg body weight in an acute
toxicity study. No tremors, salivation, diarrhea, sleep,
coma, death, or unusual behaviors such as walking back-
ward and reactivity to handling, were observed. According
to the Organization for Economic Cooperation and Devel-
opment guidelines for acute oral toxicity, a lethal 50 (LD50)tal flavonols of n-hexane fraction of Salmalia malabarica.
onoid compounds (mg QE/g) Total flavonols (mg rutin/g)
28  0.97 138.63  0.69
e experiments.
Table 2 Effect on n-hexane fraction of Salmalia malabarica at different doses on the increase blood glucose level in starch
loaded (5 g/kg body weight) rats.
Group (mg/kg) Blood glucose level (mg/dl)
0 min 30 min 60 min 120 min 180 min
Control 78.37  4.65 186.84  5.87 265.48  6.54 272.63  6.76 286.51  4.65
S. malabarica (100) 75.49  4.23 114.71  4.76* 163.69  5.63* 132.37  5.18* 104.83  4.52*
S. malabarica (200) 79.51  3.65 138.84  5.23* 196.72  5.93* 177.28  5.17* 158.47  5.52*
S. malabarica (400) 76.86  3.79 135.58  4.53* 190.91  5.74* 175.37  5.27* 153.56  4.85*
S. malabarica (600) 77.73  4.65 132.47  4.67* 185.58  7.57* 168.47  3.75* 151.64  6.35*
Acarbose (3) 76.92  4.21 117.48  4.37* 153.13  5.38* 128.19  5.17* 101.63  4.62*
Data are expressed as mean  SEM; n Z 6. ANOVA followed by multiple comparison two-tailed t test.
* p value <0.001 compared with control group.
Table 3 Median lethal dose determination of the n-hexane fraction of Salmalia malabarica administered orally to Wistar rat.
Dose (mg/kg body weight) Number of animals used Number survived Number dead Median lethal dose
0 (Control) 6 6 0 >3.0 g/kg body weight
100 6 6 0
500 6 6 0
1000 6 6 0
2000 6 6 0
3000 6 6 0
52 D. De et al.dose of 2000 mg/kg and above is categorized as unclassified
and hence the n-hexane fraction of this plant part is found
to be safe.
In conclusion, the present study reveals that the n-
hexane fraction of sepal of S. malabarica significantly in-
hibits a-amylase and a-glucosidase activity and can
decrease glucose level significantly in OSTT in a dose-
dependent manner. Although the antidiabetic activity of
S. malabarica is justified, further investigation is still in
progress to validate its action.
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